In late 2024, the government has signalled that they’re considering restrictions to puberty blocker medications for trans children, and those questioning their gender.

Our position is that there must be no additional restrictions on puberty blockers. No regulations should be developed. This issue of access to essential medicine should not be open to public debate.

Read our open statement: No need for further restrictions on puberty blockers: open statement from Te Ngākau Kahukura and other organisations and groups that serve trans communities

The Ministry of Health’s own evidence doesn’t show a need for any restrictions, and the government hasn’t made a case for why they want to restrict access to life-saving healthcare. If there were genuine issues of medical risk, we’d expect to see concerns about all children using this medicine. Instead, the focus on trans children is clearly aimed at undermining their right to make decisions about their own health.

The public consultation on possible restrictions is open until 20 January 2025. We’ll be sharing information and links on this page to help you respond.

 

Resources for responding

Official information about the review

About puberty blockers

Support to make a submission

Statements